To the full analysis
Buyback calculator for Twist Bioscience
Twist Bioscience stock: key metrics
TWSTTwist Bioscience had an operating margin of −30.4% and a return on invested capital (ROIC) of −28.3% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2016 | −315.2% | −1,924.0% | −1,943.1% |
| 2017 | −123.1% | −543.2% | −550.8% |
| 2018 | −26.6% | −277.5% | −280.2% |
| 2019 | 12.8% | −200.1% | −198.0% |
| 2020 | 31.8% | −155.5% | −155.3% |
| 2021 | 39.1% | −115.4% | −114.9% |
| 2022 | 41.4% | −115.3% | −107.0% |
| 2023 | 36.6% | −88.6% | −83.5% |
| 2024 | 42.6% | −70.6% | −66.7% |
| 2025 | 50.7% | −36.2% | −20.6% |
| 2026 | 52.4% | −30.4% | −28.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2016 | 57.5% | −49.9% | −57.7% |
| 2017 | 44.5% | −63.6% | −69.2% |
| 2018 | 35.4% | −63.4% | −61.5% |
| 2019 | −70.8% | −66.2% | −57.6% |
| 2020 | −41.6% | −42.1% | −35.1% |
| 2021 | −26.2% | −97.3% | −21.7% |
| 2022 | −27.6% | −68.0% | −22.7% |
| 2023 | −32.8% | −45.1% | −26.4% |
| 2024 | −44.2% | −52.7% | −34.0% |
| 2025 | −16.4% | −32.7% | −12.1% |
| 2026 | −14.7% | −28.3% | −11.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
- Valuation signal Fairly valued since 13 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.